FdaApplication

ANDA 206576

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTWI PHARMS INC
application_typeANDA

Products (3)

ProductActive ingredientStrengthDosage form
OXCARBAZEPINEOXCARBAZEPINE300MGTABLET, EXTENDED RELEASE;ORAL
OXCARBAZEPINEOXCARBAZEPINE600MGTABLET, EXTENDED RELEASE;ORAL
OXCARBAZEPINEOXCARBAZEPINE150MGTABLET, EXTENDED RELEASE;ORAL

3 products